HRSA - Health Resources and Service Administration U.S. Department of Health & Human Services
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health System Concerns About HRSA

The HIV/AIDS Program: HAB Performance Measures

 

HAB Performance Measures Group 2 -
Syphilis Screening

< Previous | Home | Next >

Syphilis Screening
  Performance Measure
  Numerator
  Denominator
  Patient Exclusions
  Data Element
  Data Sources
  National Goals, Targets or Benchmarks for Comparison
  Outcome Measures for Consideration
  Basis for Selection and Placement in Group 2
  US Public Health Service Guidelines
  References/Notes
 
Performance Measure: Syphilis Screening -
OPR-Related Measure: Yes
 TOP

Percentage of adult clients with HIV infection who had a test for syphilis performed within the measurement year.

 
Numerator  TOP

Number of HIV-infected clients who had a serologic test for syphilis performed at least once during the measurement year

 
Denominator  TOP

Number of HIV-infected clients who:

  • were ≥ 18 years old in the measurement year [ 1 ] or had a history of sexual activity < 18 years, and
  • had a medical visit with a provider with prescribing privileges [ 2 ] at least once in the measurement year
 
Patient Exclusions  TOP

Patients who were < 18 years old and denied a history of sexual activity

 
Data Element  TOP
  1. Is the client HIV-infected? (Y/N)
    1. If yes, is the client ≥ 18 years or reports having a history of sexual activity? (Y/N)
      1. If yes, was the client screened for syphilis during the measurement year?
 
Data Sources  TOP
  • Ryan White Program Data Report, Section 5, Items 42 and 48 may provide data useful in establishing a baseline for this performance measure
  • Electronic Medical Record/Electronic Health Record
  • CAREWare, Lab Tracker, or other electronic data base
  • HIVQUAL reports on this measure for grantee under review
  • Medical record data abstraction by grantee of a sample of records
 
National Goals, Targets, or Benchmarks for Comparison  TOP

IHI Goal: 90% [ 3 ]

National HIVQUAL Data4 ]
  2003 2004 2005 2006
Top 10%
99.0%
100.0%
100.0%
100.0%
Top 25%
90.4%
92.2%
95.7%
95.6%
Mean*
73.7%
78.5%
82.1%
80.0%

*from HAB data base

 
Outcome Measures for Consideration  TOP

Incidence of neurosyphilis in the clinic population

 
Basis for Selection and Placement in Group 2  TOP

HIV-1 infection appears to alter the diagnosis, natural history, management, and outcome of T. pallidum infection.

Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on treatment decisions that affect a sizable population. Measure has a strong evidence base supporting the use.
 
US Public Health Service Guidelines  TOP

"HIV-infected patients should be screened for behaviors associated with HIV transmission by using a straightforward, nonjudgmental approach. This should be done at the initial visit and subsequent routine visits or periodically, as the clinician feels necessary, but at a minimum of yearly. Any indication of risky behavior should prompt a more thorough assessment of HIV transmission risks. Screening for STDs should be repeated periodically (i.e., at least annually) if the patient is sexually active or if earlier screening revealed STDs. Screening should be done more frequently (e.g., at 3-6-month intervals) for asymptomatic persons at higher risk. [ 5 ] (7/18/03).

 
References/Notes  TOP

[1] Onset of sexual activity is not reliably reported or recorded. The lower age bracket of 18 years is selected for performance measurement purposes only and should not be interpreted as a recommendation about the age at which screening should begin to occur.

[2] A "provider with prescribing privileges" is a health care professional who is certified in their jurisdiction to prescribe ARV therapy.

[3] IHI Measure reads, " Percent of Patients with Annual Syphilis Screen"
( http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientswithAnnual
SyphilisScreen.htm
)

[4] ( http://www.hivguidelines.org/public_html/center/quality- of-care/hivqual-project/hivqual-workshop/03-04-natl-score-top10-25.pdf )

[5] Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52 (No. RR-12)
( http://aidsinfo.nih.gov/ContentFiles/HIVPreventionInMedCare_TB.pdf or http://aidsinfo.nih.gov/ContentFiles/HIVPreventionInMedCare_TB.pdf )